WuXi AppTec, the Chinese pharma giant with extensive ties with U.S. companies, appears to be thriving now that the threat of ...

ROAI isn't about flashy demos or model size. It's about measurable improvements,” writes Sanofi CEO Paul Hudson.

We both lost our jobs as public health diplomats with the U.S. Agency for International Development last summer. Our termination from federal service also meant that both of us lo ...

During a two-hour experimental chat with a therapist chatbot character, it “actively encouraged me to disregard my ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

Most Medicare enrollees will face premiums that are 10% higher next year, creating budget anxiety for millions of seniors.

Republicans want to replace enhanced ACA tax credits with direct payments to individuals. Their think tank allies aren’t so ...

Restrictions on gender-affirming care for minors consistently allow exceptions for minors with intersex traits, a new study ...

Merck is buying Cidara Therapeutics for $9.2B, picking up an experimental flu therapy as it looks to broaden its pipeline.

The deals keeps coming. Merck this morning said it will acquire Cidara Therapeutics, the maker of an experimental flu therapy ...

When the Supreme Court struck down the federal ban on sports betting in 2018, Americans legally wagered less than $5 billion ...

The FDA is reversing a 2003 decision that put a stringent warning on hormone therapy products for menopausal women, saying ...